EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Tanyu Tongzhi Formula enhances IL-10 expression and macrophage efferocytosis to alleviate atherosclerosis in mice

Chenxia Wu, Tiantian Zheng, Li Wu, Zhengtian Lv, Mingshuang Li, Luoxia Hu, Youjin Kong, Xinyi Li, Zheng Rong, Chenchen Meng, Xinbin Zhou, Tingting Chen und 3 weitere

Phytomedicine · 2025

DOI: 10.1016/j.phymed.2025.157122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2025. Verfasst von Chenxia Wu und 14 weiteren Autor:innen. Beteiligte Einrichtung: The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; Department of Cardiology, Affiliated Zhejiang Hospital, …. Hauptthemen laut MEDLINE: Interleukin-10, Atherosclerosis, Drugs, Chinese Herbal, Macrophages. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Scientific Research and Technological Development Council of Veracruz, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Traditional Chinese Medicine (TCM), a significant subdiscipline within the realm of complementary medicine, has witnessed a surge in popularity across both Asian and Western nations over the past few decades. It holds potential as an adjunctive therapy for the management of atherosclerotic cardiovascular disease (ACVD). Tanyu Tongzhi Formula (TTF) -a TCM formula with decades of clinical application-has been demonstrated through completed randomized, controlled multicenter clinical studies to extend the maximum exercise duration in patients with chronic coronary syndrome and ameliorate TCM syndromes. TTF emerges as a promising therapeutic candidate for coronary artery disease characterized by phlegm stasis interaction. Additionally, TTF has demonstrated efficacy in protecting against atherosclerosis in murine models. However, the mechanisms by which TTF modulates macrophage function in atherosclerosis remain to be elucidated. PURPOSE: To investigate IL-10-dependent efferocytosis regulation as a pivotal mechanism underlying TTF's modulation of macrophage function in atherosclerosis. STUDY DESIGN AND METHODS: Low-density lipoprotein receptor or Apolipoprotein E null mice were subjected to a western diet for 8 weeks to induce atherosclerosis, after which they received TTF treatment for an additional 12 weeks. RNA sequencing was employed to identify interleukin-10 (IL-10) as a key downstream molecule. To verify the role of IL-10 in mediating the effects of TTF in reducing atherosclerosis, macrophage-specific IL-10 knockout mice were used. RESULTS: TTF administration significantly alleviated atherosclerosis in mice, evidenced by a reduction in atherosclerotic lesions and plaque necrosis, alongside an augmentation in collagen content. RNA sequencing revealed a substantial upregulation of IL-10 following TTF treatment, which corroborated in various macrophage populations and within mouse atherosclerotic plaques. IL-10 plays a crucial role in mediating the effects of TTF by enhancing macrophage efferocytosis. Notably, the targeted deletion of IL-10 in macrophages attenuated the therapeutic efficacy of TTF in mouse models of atherosclerosis. Furthermore, TTF activated the NF-κB pathway, leading to increased IL-10 expression. Trichosanthes kirilowii and Acorus tatarinowii were identified as the two functional components in TTF. CONCLUSION: IL-10-mediated efferocytosis potentiation is the critical pathway through which TTF stabilizes atherosclerotic plaques. The NF-κB/IL-10/efferocytosis axis provides a novel pharmacological target for macrophage-directed anti-atherosclerotic therapies. Tanyu Tongzhi Formula participates in the above regulatory mechanism and significantly alleviates atherosclerosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interleukin-10AtherosclerosisDrugs, Chinese HerbalMacrophagesAnimalsMiceMaleMice, Inbred C57BLMice, KnockoutReceptors, LDLPhagocytosisNF-kappa BEfferocytosis

Stichwörter der Autor:innen

AtherosclerosisEfferocytosisIl-10MacrophageTanyu tongzhi formula

Substanzen

Interleukin-10Drugs, Chinese HerbalIL10 protein, mouseReceptors, LDLNF-kappa B

Autor:innen und Institutionen

  • The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China; Department of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China.
  • Department of Cardiology, Affiliated Zhejiang Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Cardiology, The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, China.
  • Zhejiang Key Laboratory of Integrative Chinese and Western Medicine for Diagnosis and Treatment of Circulatory Diseases, Hangzhou, China; Zhejiang Engineering Research Center for Precise Diagnosis and Innovative Traditi…
  • Key Laboratory of Regenerative Medicine of Ministry of Education, Institute of Aging and Regenerative Medicine, Jinan University, Guangzhou, China. Electronic address: zhenyuju@163.com.

Förderung

  • Scientific Research and Technological Development Council of Veracruz
  • National Natural Science Foundation of China

Zitieren

APA

Wu, C., Zheng, T., Wu, L., Lv, Z., Li, M., Hu, L., Kong, Y., Li, X., Rong, Z., Meng, C., Zhou, X., Chen, T., Ju, Z., Cheng, H., & Mao, W. (2025). The Tanyu Tongzhi Formula enhances IL-10 expression and macrophage efferocytosis to alleviate atherosclerosis in mice. Phytomedicine. https://doi.org/10.1016/j.phymed.2025.157122

Vancouver

Wu C, Zheng T, Wu L, Lv Z, Li M, Hu L, et al. The Tanyu Tongzhi Formula enhances IL-10 expression and macrophage efferocytosis to alleviate atherosclerosis in mice. Phytomedicine. 2025. doi:10.1016/j.phymed.2025.157122

BibTeX
@article{Wu2025,
  author = {Wu, Chenxia and Zheng, Tiantian and Wu, Li and Lv, Zhengtian and Li, Mingshuang and Hu, Luoxia and Kong, Youjin and Li, Xinyi and Rong, Zheng and Meng, Chenchen and Zhou, Xinbin and Chen, Tingting and Ju, Zhenyu and Cheng, Hongqiang and Mao, Wei},
  title = {The Tanyu Tongzhi Formula enhances IL-10 expression and macrophage efferocytosis to alleviate atherosclerosis in mice},
  journal = {Phytomedicine},
  year = {2025},
  doi = {10.1016/j.phymed.2025.157122}
}
Kostenlos starten →